MedPath

Effect of Extracorporeal Shock Therapy for Dysmenorrhea

Not Applicable
Completed
Conditions
Primary Dysmenorrhea
Interventions
Device: Extracorporeal Shock wave
Registration Number
NCT04741243
Lead Sponsor
Cairo University
Brief Summary

This study was carried out upon forty women diagnosed as primary dysmenorrhea. They were selected from outpatient clinics of gynecology of Ain Shams University Hospital, Cairo University. Their age ranged from 25-35 years, BMI\<30kg/ m².

Detailed Description

Patients with primary dysmenorrhea diagnosed by a physician, spondylolisthesis and chronic low back pain were excluded from the study. They were randomly assigned into two equal groups (A\& B). Group (A) consisted of twenty subjects, with an average age 29.2±1.9Yrs, and BMI 27.28±2.1kg/m2 who received Extracorporeal shock waves. Group (B) consisted of twenty patients, with an average age 28.58±2.2Yrs, and BMI 28.92±0.7kg/m2 who received sham technique. A hot pack was used for 15 minutes for both groups (A\&B) before the treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • forty virgin females.
  • their age ranged between 25 to 35 years old.
  • Body mass index (BMI) <30kg/ m².
Exclusion Criteria
  • females with pelvic pathology as endometriosis.
  • females have irregular menstrual cycles.
  • females have secondary dysmenorrhea.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Extracorporeal shock wave therapyExtracorporeal Shock wavewas used for 15 minutes in a prone position for both groups (A\&B) before the treatment. shock wave were used to heat small areas, and allow for decrease pain, muscle spasm, and provide vasodilatation of the blood vessels supplying the area
dietary modificationExtracorporeal Shock waveDietary modifications are changes made during food preparation, processing, and consumption to increase the bioavailability of micronutrients-and reduce micronutrient deficiencies-in food at the commercial or individual/household level.
Primary Outcome Measures
NameTimeMethod
Visual Analogue Scalethree months

Visual analogue scale: that was used to determine the pain intensity level. It consists of 10 cm as a horizontal line with one end represented that (0= no pain) and the other end (10= worst pain). The assessment was performed for every woman in both groups (A, B) before and after the treatment program.

Secondary Outcome Measures
NameTimeMethod
analysis of circulating β-endorphinthree months

assessment of circulating β-endorphin was done before and after the treatment progam

Trial Locations

Locations (1)

Ghada Elrefaye

🇪🇬

Giza, Cairo, Egypt

Ghada Elrefaye
🇪🇬Giza, Cairo, Egypt
© Copyright 2025. All Rights Reserved by MedPath